Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 12:33 AM
Ignite Modification Date: 2025-12-25 @ 10:40 PM
NCT ID: NCT02486367
Description: None
Frequency Threshold: 0
Time Frame: 30days
Study: NCT02486367
Study Brief: Inflammation and Thrombosis in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement (TAVR)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Standard Care/Clopidogrel 300mg load followed by 75mg daily. Clopidogrel: Standard ADP receptor blockade 0 None 11 30 0 30 View
Ticagrelor 180mg load followed by 90mg twice daily for 30 days. Ticagrelor: High potency ADP receptor blockade 0 None 8 30 0 30 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Major (TIMI3a or above) bleeding event NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Permanent pacemaker placement NON_SYSTEMATIC_ASSESSMENT Cardiac disorders None View
Other Events(If Any):